Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

VASERETIC

ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE

Standard Dose
10MG;25MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview VASERETIC is listed in Drugs@FDA under application 019221 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 10MG;25MG Sponsor BAUSCH Submission history Latest submission status date: 2020-08-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview VASERETIC is listed in Drugs@FDA under application 019221 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 10MG;25MG Sponsor BAUSCH Submission history Latest submission status date: 2020-08-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.